This interaction also occurs in vivo, as the GAG sidechains of HSPGs are observed to colocalize with tau-based lesions in the brains of patients suffering from both AD and other tauopathies (Snow et al., 1990; Su et al., 1992). This evidence concerns the gene MAPT and Alzheimer disease.